Dijon, France

Christine Massardier

This inventor holds 5 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignees: Laboratoires Fournier Sa, Inventiva, Laboratories Fournier S.a.. Active years: 2008-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christine Massardier. Retrieved from https://idiyas.com/inventor/christine-massardier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 80.0

 

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 2008-2024

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Christine Massardier: Innovator in Cancer and Disease Treatment

Introduction

Christine Massardier, an accomplished inventor based in Dijon, France, has made significant contributions to the field of pharmaceuticals. With a portfolio of five patents, she has focused her research on innovative treatments targeting various diseases, including cancer and neurodegenerative conditions.

Latest Patents

Massardier's latest inventions include groundbreaking patents:

1. **Inhibitors of the YAP/TAZ-TEAD interaction and their use in the treatment of cancer** - This invention involves compounds that aim to disrupt specific interactions within cellular pathways, offering potential advancements in cancer therapies.

2. **LXR receptor modulators** - This patent covers benzenesulfonamide derivative compounds that can be utilized as pharmacologically active substances. These compounds are particularly promising for treating neurodegenerative diseases, cardiovascular diseases, inflammatory diseases, hypercholesterolemia, and diabetes.

Career Highlights

Throughout her career, Christine has worked with prestigious companies such as Laboratoires Fournier S.A. and Laboratories Fournier S.A. Her work in these organizations has significantly impacted the development of new pharmaceutical compounds and treatment methodologies.

Collaborations

Christine has collaborated with notable colleagues, including Martine Barth and Michel Bondoux. Together, they have fostered innovative research and development projects that have led to successful patent applications and advancements in their respective fields.

Conclusion

Christine Massardier exemplifies dedication and innovation in pharmaceutical sciences. Her contributions through her patents not only pave the way for new treatment options but also highlight the importance of collaborative efforts in research and development. As the landscape of medical treatments continues to evolve, her work stands as a testament to the vital role of inventors in improving health outcomes worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…